
Nanovery is a biotechnology company pioneering the use of DNA nanorobotics technology to revolutionize nucleic acid detection and RNA therapeutic analysis. Their platform uses custom-built nanorobotic sensors to accurately quantify nucleic acid sequences in biological samples with a simple two-step workflow, significantly reducing effort, cost, and time compared to traditional methods. The company focuses on RNA therapeutic bioanalysis, including antisense oligonucleotides (ASO), siRNA, and microRNA biomarkers, providing robust, easy-to-use assays that enhance research precision and simplify testing protocols. Nanovery operates with a data-driven approach, leveraging DNA nanotechnology and AI to scale nucleic acid testing, positioning itself as an innovator in the biotech research and diagnostics market. The company is based in the United Kingdom and led by a team of experienced scientists and entrepreneurs committed to advancing biotechnology through cutting-edge nanotechnology and computational methods.

Nanovery is a biotechnology company pioneering the use of DNA nanorobotics technology to revolutionize nucleic acid detection and RNA therapeutic analysis. Their platform uses custom-built nanorobotic sensors to accurately quantify nucleic acid sequences in biological samples with a simple two-step workflow, significantly reducing effort, cost, and time compared to traditional methods. The company focuses on RNA therapeutic bioanalysis, including antisense oligonucleotides (ASO), siRNA, and microRNA biomarkers, providing robust, easy-to-use assays that enhance research precision and simplify testing protocols. Nanovery operates with a data-driven approach, leveraging DNA nanotechnology and AI to scale nucleic acid testing, positioning itself as an innovator in the biotech research and diagnostics market. The company is based in the United Kingdom and led by a team of experienced scientists and entrepreneurs committed to advancing biotechnology through cutting-edge nanotechnology and computational methods.